SSG
OGN icon

Summit Securities Group’s Organon & Co OGN Stock Holding History

Summit Securities Group’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,000
Closed -$314K – 1156
2022
Q1 		$314K Buy
+9,000
New +$308K 0.04% 301

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Summit Securities Group's OGN Position: Q1 2026 in Review

Summit Securities Group sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 9,100 shares — an estimated $65.2K sold.

Summit Securities Group first reported a position in OGN in Q1 2022 and held it in 14 quarters. The position peaked at $451K in Q2 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Summit Securities Group reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Summit Securities Group sold 9,100 Organon & Co shares in Q1 2026, an estimated $65.2K.
  • Summit Securities Group first reported a position in Organon & Co in Q1 2022 and held it in 14 quarters.
  • Summit Securities Group's Organon & Co position peaked at $451K in Q2 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.